ESC 365 - PACIFIC-STROKE - Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334

Back

ESC Professional Premium Access

PACIFIC-STROKE - Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – non-cardioembolic STROKE study.

Session: HOT LINE SESSION 5

Topic: Prevention

Speaker: Doctor A. Shoamanesh (Hamilton, CA)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Ashkan Shoamanesh

McMaster University, Hamilton (Canada)

1 presentation

0 follower

11 more presentations in this session

INVICTUS - Rivaroxaban versus VKA for rheumatic atrial fibrillation.

Speaker: Professor G. Karthikeyan (New Delhi, IN)

Discussant review - INVICTUS.

Speaker: Professor R. Lopes (Durham, US)

Access

Slides

Video

Panel discussion - INVICTUS.

Access

Video

PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction .

Speaker: Professor J. Alexander (Durham, US)

Discussant review - PACIFIC-AMI.

Speaker: Doctor M. O'Donoghue (Boston, US)

Access

Slides

Video

Access the full session

HOT LINE SESSION 5

Speakers: Doctor A. Shoamanesh, Professor G. Karthikeyan, Professor R. Lopes, Professor J. Alexander, Doctor M. O'Donoghue

Access

Video

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources